Recordati stock edges higher as takeover bid faces activist pushback
Published on 09/15/2026 at 18:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Recordati stock (ISIN IT0003828271) recently closed at EUR 52.00 on Euronext Milan on September 11, 2026, leaving the shares modestly above the EUR 51.29 per share voluntary takeover offer on the table and signaling that investors are pricing in some upside potential beyond the bid price, according to Borsa Italiana data compiled in recent market overviews.
Takeover bid keeps Recordati stock above offer price
The central catalyst for Recordati stock in mid-September 2026 is a voluntary full takeover bid launched by Respighi BidCo, a vehicle of CVC Capital Partners and Groupe Bruxelles Lambert (GBL), at EUR 51.29 per share for the company’s ordinary shares. As detailed in Italian market coverage, the offer has drawn a mixed response from shareholders, with the market price trading consistently above the bid level.Il Sole 24 Ore
On September 14, 2026, Recordati shares were reported at about EUR 52.25 on Euronext Milan, modestly above both the September 11, 2026 close and the EUR 51.29 per share offer, implying a market premium of roughly 1.9 percent to the bid price and suggesting that investors expect either a higher bid or that the company has standalone value exceeding the current proposal.Ad-hoc-news
Activist investor challenges valuation of the CVC-GBL offer
A key development shaping sentiment is the intervention of activist investor Palliser Capital, which has publicly argued that the EUR 51.29 per share bid undervalues Recordati. According to coverage from a major Italian financial daily, Palliser wrote to Recordati’s board urging it to withdraw support for the takeover offer, highlighting both the company’s long-term prospects and the modest premium implied by the bid compared with recent trading levels.Il Sole 24 Ore
Investor pushback has translated into a relatively high but not overwhelming level of acceptances. As of September 15, 2026, Italian market data indicate that the number of acceptance requests for the takeover bid reached around 98.28 million shares, representing approximately 49.5 percent of the total securities subject to the offer, leaving the offer short of full control and showing that a significant minority of shareholders has held back from tendering at the current price.Teleborsa
The acceptance window for the offer began on August 31, 2026 and is scheduled to close on October 15, 2026, giving shareholders several more weeks to decide whether to tender. Italian exchange guidance notes that ordinary Recordati shares purchased in the market on October 14 and October 15, 2026 will not be eligible to be contributed to the offer, an operational detail that may influence short-term trading strategies as the deadline approaches.Teleborsa
Market reaction and recent price performance
Recent trading shows that Recordati stock has held above the offer price in a volatile broader market. Market data compiled in early September 2026 indicate that the shares closed at EUR 52.00 on Euronext Milan on September 11, 2026, unchanged on the day, leaving the daily percent change at 0.00 percent and positioning the stock modestly positive year to date at about 7.13 percent in a choppy European equity environment.Ad-hoc-news
Commentary on Italian blue-chip trading highlights that defensive healthcare names have recently provided relative support to the FTSE MIB index. In one overview of Milan trading, Recordati and peer DiaSorin were cited as posting gains in the range of roughly 0.8 to 1.0 percent on September 14, 2026, standing out among the limited number of constituents in positive territory when the index itself declined around 2.0 percent on renewed pressure on cyclical shares.Ad-hoc-news
Further market commentary from a European stock portal notes that Recordati rose about 0.7 percent to EUR 52.35 per share in one of the latest sessions in mid-September, again staying above the EUR 51.29 bid and underscoring that the market is assigning a premium relative to the offer price.MarketScreener
Fundamentals and valuation backdrop
While the current takeover debate dominates short-term trading, the bid level and activist criticism are implicitly anchored in Recordati’s financial fundamentals and sector position. Recordati is a long-established Italian pharmaceutical and healthcare group with a portfolio spanning specialty and primary care medicines, and investors comparing the EUR 51.29 offer to recent trading around EUR 52.00 to EUR 52.35 must weigh the implied valuation multiple against the company’s latest reported revenues, earnings and cash flows, which underpin the activist case that the offer undervalues the business.Il Sole 24 Ore
The voluntary nature of the takeover bid means that investors are not compelled to tender and can opt to stay invested in Recordati, hoping for either a revised higher offer or continued independent value creation. The modest but consistent premium of market price over the bid level acts as an indicator of this expectation: for example, the price of EUR 52.25 on September 14, 2026 represents a small but tangible uplift compared with the EUR 51.29 bid, while the EUR 52.35 level cited in recent market commentary extends that gap slightly further, reinforcing the perception that the offer has not fully convinced the market.Ad-hoc-news
From an investor perspective, the activist challenge and acceptance level around 49.5 percent suggest that negotiations about the appropriate valuation of Recordati’s equity are still in flux. The offer period running until October 15, 2026 leaves room for potential changes in terms, and the defensive profile of healthcare stocks in the current Italian market environment gives shareholders an additional argument for resisting a sale at what is seen as a relatively low premium.
Recordati stock price level on Euronext Milan
For orientation, Recordati stock most recently finished a completed session at EUR 52.00 on Euronext Milan on September 11, 2026, matching the prior day’s settlement and leaving the daily percent change at 0.00 percent. Market tables for Borsa Italiana show the shares up around 0.19 percent over the previous five sessions and about 7.13 percent year to date at that closing level, placing the price within its recent trading corridor and modestly above the EUR 51.29 takeover offer.Ad-hoc-news
Recordati stock - key data
- Company: Recordati S.p.A.
- ISIN: IT0003828271
- Ticker: REC
- Trading venue: Euronext Milan
- Price (as of September 11, 2026): 52.00 EUR
- Sector / Industry: Pharmaceuticals / Healthcare
- Index membership: FTSE MIB
